The genomic landscape of lung adenocarcinoma—insights towards personalized medicine-Reference-Cited by-同舟云学术

The genomic landscape of lung adenocarcinoma—insights towards personalized medicine

Published:2021-10-22 Issue:4 Volume:87 Page:562-577
ISSN:0370-0046
Container-title:Proceedings of the Indian National Science Academy
language:en
Short-container-title:Proc.Indian Natl. Sci. Acad.

Author:

Kour Ovleen,Garg Minakshi

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s43538-021-00054-1.pdf

Reference111 articles.

1. Addissie, Y.A., Kotecha, U., Hart, R.A., Martinez, A.F., Kruszka, P., Muenke, M.: Craniosynostosis and Noonan syndrome with KRAS mutations: expanding the phenotype with a case report and review of the literature. Am. J. Med. Genet. Part A 167A, 2657–2663 (2015)

2. Alessandro, L., Sharma, S., Minari, R., Perego, P., Giovannetti, E., Tiseo, M.: Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br. J. Cancer 121(9), 725–737 (2019)

3. Amini, A., Yeh, N., Gaspar, L.E., Kavanagh, B., Karam, S.D.: Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat. Oncol. 9:210 (2014)

4. Amos, C.I., Wu, X., Broderick, P., Gorlov, I.P., Gu, J., Eisen, T., et al.: Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 40, 616–622 (2008)

5. Arbour, K.C., Riely, G.J.: Diagnosis and treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer. Hematol. Oncol. Clin. n. Am. 31, 101–111 (2017)